Mind & Matter
Mind & Matter
Deuterium, Metabolic Water & Cancer | Gábor Somlyai | Episode 297
0:00
-1:30:44

Paid episode

The full episode is only available to paid subscribers of Mind & Matter

Deuterium, Metabolic Water & Cancer | Gábor Somlyai | Episode 297

The possible role of deuterium (heavy isotope of hydrogen) in regulating cell division, mitochondrial metabolism & cancer.

Wide release: June 18, 2026. Not medical advice.


Nick speaks with Gábor Somlyai, PhD about the biological role of deuterium, a heavier, non-radioactive isotope of hydrogen present in water and organic molecules. Somlyai’s key argument is that small shifts in the deuterium-hydrogen (D-H) ratio act as a fundamental regulator of cell growth, with deuterium-depleted water (DDW) inhibiting tumor progression. They explore mitochondrial production of naturally deuterium-depleted metabolic water, deuterium’s effects on biochemical reaction rates, evidence from cell culture and animal models, and human clinical data showing improved outcomes in cancer patients using DDW as an adjunct therapy.



TOPICS DISCUSSED:

  • Deuterium Basics: Deuterium is twice as massive as regular hydrogen; natural water contains ~150 ppm, with stronger oxygen-deuterium bonds slowing reactions compared to oxygen-hydrogen.

  • Mitochondrial Role: Healthy mitochondria produce deuterium-depleted metabolic water (~110 ppm from fat oxidation vs. ~150 ppm from carbs), helping maintain low cellular D:H ratios.

  • Cell Growth Regulation: Lower deuterium slows cell division in vitro; cells sense small D:H changes, with higher levels (near/above 150 ppm) promoting growth.

  • In Vitro Evidence: DDW (e.g., 25-125 ppm) can reduce proliferation and alters cancer-related gene expression.

  • Animal Models: DDW caused tumor regression in mice with transplanted human cancers and showed possible efficacy in veterinary use for dogs and cats.

  • Human Prostate Cancer: Phase 2 randomized study showed greater Prostate-Specific Antigen (PSA) reduction, tumor shrinkage, and better 1-year survival with DDW plus standard therapy vs. placebo.

  • Dietary Modulation: Ketogenic/high-fat diets lower body deuterium from lipid oxidation.

  • Broader Implications: Potential in neurodegeneration models; larger trials needed for registration as adjunct cancer therapy.


ABOUT THE GUEST: Gábor Somlyai, PhD is a molecular biologist who pioneered deuterium depletion studies at the National Institute of Oncology in Hungary. His primary work focuses on the role of deuterium in living organisms and the development of deuterium-depleted water for cancer therapy.


RELATED CONTENT:

  • M&M 221: Regenerative Energy & the Light Inside You | Jack Kruse


KNOW YOURSELF:

  • Visit the SUPPORT PAGE if you find value in this content. Includes discount codes + links to affiliate partners, including products to help you measure and manage your health.


Listen or watch on your favorite platform:


PRACTICAL TAKEAWAYS:

  • Drink deuterium-depleted water (DDW) at targeted concentrations (e.g., 85-105 ppm) for months may act as a potential adjunct to standard care in oncology, following established protocols.

  • Prioritize high-fat, low-carbohydrate (ketogenic-style) eating to naturally reduce bodily deuterium levels through mitochondrial metabolism.


SUBSCRIBER CONTENT BELOW: Reference paper + episode transcript.

Listen to this episode with a 7-day free trial

Subscribe to Mind & Matter to listen to this post and get 7 days of free access to the full post archives.